Clinical Trials Browser

Phase 2 × ascrinvacumab × Genitourinary × Clear all

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Camurati-Engelmann Syndrome, Neoplasm Metastasis, Recurrence